- Home
- DFLI vs LPCN Comparison
DFLI vs LPCN Comparison
Compare DFLI & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFLI
- LPCN
- Stock Information
- Founded
- DFLI 2020
- LPCN 1997
- Country
- DFLI United States
- LPCN United States
- Employees
- DFLI N/A
- LPCN N/A
- Industry
- DFLI Electronic Components
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- DFLI Technology
- LPCN Health Care
- Exchange
- DFLI Nasdaq
- LPCN Nasdaq
- Market Cap
- DFLI 5.0M
- LPCN 16.1M
- IPO Year
- DFLI N/A
- LPCN N/A
- Fundamental
- Price
- DFLI $0.54
- LPCN $3.19
- Analyst Decision
- DFLI Strong Buy
- LPCN Strong Buy
- Analyst Count
- DFLI 4
- LPCN 1
- Target Price
- DFLI $12.83
- LPCN $10.00
- AVG Volume (30 Days)
- DFLI 265.0K
- LPCN 11.1K
- Earning Date
- DFLI 05-13-2025
- LPCN 05-08-2025
- Dividend Yield
- DFLI N/A
- LPCN N/A
- EPS Growth
- DFLI N/A
- LPCN N/A
- EPS
- DFLI N/A
- LPCN N/A
- Revenue
- DFLI $50,645,000.00
- LPCN $11,198,144.00
- Revenue This Year
- DFLI $42.48
- LPCN N/A
- Revenue Next Year
- DFLI $42.95
- LPCN N/A
- P/E Ratio
- DFLI N/A
- LPCN $2,043.54
- Revenue Growth
- DFLI N/A
- LPCN N/A
- 52 Week Low
- DFLI $0.46
- LPCN $2.75
- 52 Week High
- DFLI $13.14
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- DFLI 24.41
- LPCN 50.69
- Support Level
- DFLI $0.46
- LPCN $2.82
- Resistance Level
- DFLI $0.67
- LPCN $3.27
- Average True Range (ATR)
- DFLI 0.09
- LPCN 0.21
- MACD
- DFLI 0.02
- LPCN 0.03
- Stochastic Oscillator
- DFLI 16.10
- LPCN 71.94
About DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.